MeSH tree: D12.644.233
As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new antibiotic on the scene—ibezapolstat—which ...
Sep 4, 2025
0
120
Cancer cells have one relentless goal: to grow and divide. While most stick together within the original tumor, some rogue cells break away to traverse to distant organs. There, they can lie dormant—undetectable and not dividing—for ...
Sep 4, 2025
0
32
A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated Staphylococcus aureus bloodstream infections with two intravenous (IV) doses of the antibiotic dalbavancin ...
Aug 13, 2025
0
21
C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive system. It is one of the most common causes of diarrhea linked to antibiotic use, particularly in ...
Aug 5, 2025
0
14
In a randomized pilot study recently published in the Journal for ImmunoTherapy of Cancer, an international research team led by Andrea Facciabene, Ph.D., and Steven Joel Feigenberg, MD, both of the Department of Radiation ...
Jul 29, 2025
0
14
University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during antibiotic therapy.
A fecal transplant performs as well as antibiotics in treating people with a bacterial infection that can cause life-threatening diarrhea, a new study says.
Jun 20, 2025
0
22
Obesity can have a distinct impact on the absorption, effectiveness and excretion of antibiotics, medications that have been in use for more than 80 years, but only now have consensus guidelines been proposed on prescribing ...
Symptoms that persist long after Lyme disease is treated are not uncommon—a 2022 study found that 14% of patients who were diagnosed and treated early with antibiotic therapy would still develop Post Treatment Lyme Disease ...
Apr 23, 2025
1
46
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United States annually. CD8+ T cells that normally kill cancer cells often become exhausted and stop.
Mar 28, 2025
0
31
